CRISPR
Down 21% This Year, Is CRISPR Therapeutics Stock Still a Buy?
New kit makes classroom CRISPR experiments affordable and accessible
Crispr Therapeutics: Prepare To Be Bored
Crispr-Enhanced Viruses Are Being Deployed Against UTIs
From CRISPR to Prime Editing: The Evolution of the Genome Editing Revolution
Nobel Prize-Winning Biochemist Dr. Jennifer Doudna to Speak at UCSB
CRISPR Therapeutics AG (CRSP) Dips More Than Broader Market: What You Should Know
CRISPR-Inspired AI Toolkit Simulates Thousands of Experiments in a Virtual Lab
Crispr Therapeutics: Casgevy Now Active Across 35 Treatment Centres
Genetic Engineering
Greenhouse gains: Cucumbers get a genetic upgrade through innovative pollen tech
Genetic engineering
Successful detection methods for new genomic techniques
Cucumbers Enhanced by New Genetic Pollen Tech
Genetic Engineering: Reshaping Life at the Molecular Level
Genetic engineering was meant to save chestnut trees. Then there was a mistake.
Republicans, Democrats at odds over IVF bill
Genetic Engineering May Create More Effective Cannabis Varieties
Global Genetic Engineering Market Size To Worth USD 8.95 Billion By 2033 | CAGR Of 20.82%
Genetic engineering articles from across Nature Portfolio
Gene Editing
Kibbutz ravaged on Oct. 7 looks to renewal through gene-edited vegetable trials
Pairwise Raises $40M in Series C, Inks Gene Editing Agreement with Corteva
Building better DNA editors: Retrons raise the bar for gene research
Corteva invests $25 million in NC startup Pairwise to accelerate gene-editing efforts
From 'science fiction to reality': New George Church-founded biotech raises $75M for cell therapy platform
Gene editing firm Pairwise closes new $40MM Series C funding, announces Corteva joint venture
The great gene editing debate: can it be safe and ethical?
Vandals Destroyed Italy’s First Gene-Edited Crop, But There’s Good News
Pairwise raises $40m series C, forms JV with Corteva to accelerate gene editing on row crops
CRISPR Therapy
Down 21% This Year, Is CRISPR Therapeutics Stock Still a Buy?
The world's 1st CRISPR therapy has just been approved. Here's everything you need to know
Understanding CRISPR Therapy
Vertex, CRISPR’s Casgevy Highlights Complex Path to Gene Therapy Profitability
CRISPR gene therapy improves vision in people with inherited blindness
Breaking the Chains: How CRISPR Gene Therapy Gave Victoria Gray a New Life
CRISPR Cas9 Market Opportunity & Clinical Trials Market Outlook to 2029: Focus on Approved CRISPR-Cas9 Therapy - Casgevy (Exagamglogene Autotemcel) Therapy Clinical Insight ...
FDA Decision Looms on First Crispr-Based Therapy
CRISPR/Cas9-mediated gene editing therapy shows efficacy in latent rabbit model of HSV-1 keratitis
CRISPR Cas9 Market and Clinical Trials Report to 2029: CRISPR-Cas9 Therapy Clinical Trials By Company, County, Indication & Phase
DNA
Lawmakers move to limit police use of DNA from babies and crime victims
Thanks to DNA advances, man given 20-year term for 1984 murder in Uptown residence
DNA test reunites litter mates
For Kansas rape survivors, DNA evidence has failed to deliver
DNA tests on body believed to be alleged I-75 shooter Joseph Couch came back ‘inconclusive’
Insights into South African population history from 10,000-year-old human DNA
23andMe Board Resigns in New Blow to DNA-Testing Company
Victim statement, DNA evidence connect Grain Valley man to 2013 rape case
Mark Pope prioritizes players with winning DNA when building a roster
DNA Sequencing
Insights into South African population history from 10,000-year-old human DNA
GeneDx Stock Rocketed 1310% In Dramatic Turnaround Powered By DNA Analytics
Remains of unidentified woman from 1968 Will County cold case exhumed, sent for DNA sequencing
DNA-Sensing Enzyme Wins the 2024 Lasker Award
Unveiling the mechanism behind DNA organization in early embryos
DNA sequencing
DNA sequencing: generation next-next
Researchers Bend DNA Strands with Light, Revealing a New Way to Study the Genome
Genomics 101: What is non-coding DNA?